Mina M. Rizk, MD

  • 1Article
  • 6.8KReads
  • 2024Active
  • 7Collaborators
  • 18Citations

About

Mina M. Rizk, MD is affiliated with Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York. Mina M. Rizk has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2024. Their work focuses on Depression (MDD).

Publications

JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe